← Back to patent-cliff list
CAS 307345-97-7
(3S,4R)-4-hydroxytetrahydrofuran-3-aminium 4-methylbenzenesulfonate
Codes: NELF-024
Application context (from source-drug indications)
HIV infectionNelfinavir MesylateMyelofibrosisNelfinavir Mesylate子宫颈功能不全Nelfinavir MesylateSystemic lupus erythematosusNelfinavir MesylateNon-small cell lung cancerNelfinavir Mesylate巨细胞病毒性视网膜炎Nelfinavir Mesylate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Nelfinavir Mesylate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(3S,4aS,8aS)-N-(tert-butyl)decahydroisoquinoline-3-carboxamide→(3S,4R)-4-hydroxytetrahydrofuran-3-aminium 4-methylbenzenesulfonate→3-(((3S,4R)-4-hydroxytetrahydrofuran-3-yl)carbamoyl)-2-methylphenyl acetate→3-((S)-4-((R)-2-acetoxy-1-((methylsulfonyl)oxy)ethyl)-4,5-dihydrooxazol-2-yl)-2-methylphenyl acetate→(3S,4aS,8aS)-N-(tert-butyl)-2-((R)-2-hydroxy-2-((S)-2-(3-hydroxy-2-methylphenyl)-4,5-dihydrooxazol-4-yl)ethyl)decahydroisoquinoline-3-carboxamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.